secwatch.observer — SEC 8-K summary
======================================

Issuer:     Absci Corp (ABSI)
CIK:        0001672688
Form:       8-K
Filed at:   2022-11-09T23:59:59+00:00
Accession:  0001628280-22-029091
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Absci Q3 revenue $2.4M; cash burn guidance improved to ~$105M for 2022
----------------------------------------------------------------------

- Cash and short-term investments $181.3M at Sep 30, down from $206.0M at Jun 30; operating cash use $19.0M in Q3.
- Q3 revenue $2.4M vs $1.5M YoY, driven by Merck collaboration milestone and nsAA technology progress.
- R&D expense $15.5M (+45% YoY); SG&A $11.4M; includes $2.7M severance charges.
- Exceeded 2022 Active Program guidance: 10 signed YTD vs 8 target; total Active Programs now 17.
- Appointed Andreas Busch as Chief Innovation Officer and Dan Rabinovitsj to Board; cash runway into late 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1672688/000162828022029091/0001628280-22-029091-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1672688/000162828022029091/absc-20221109.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-029091

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer